300026 红日药业
午间休市 11-20 11:30:00
资讯
新帖
简况
10月25日红日药业现2笔折价20%的大宗交易 合计成交2187.81万元
证券之星 · 10-25
10月25日红日药业现2笔折价20%的大宗交易 合计成交2187.81万元
红日药业(300026.SZ)发布前三季度业绩,净利润1.68亿元,同比下降66.94%
智通财经 · 10-24
红日药业(300026.SZ)发布前三季度业绩,净利润1.68亿元,同比下降66.94%
红日药业(300026)9月30日股东户数11.08万户,较上期减少0.76%
证券之星 · 10-24
红日药业(300026)9月30日股东户数11.08万户,较上期减少0.76%
10月8日红日药业涨9.58%,银河康乐股票A基金重仓该股
证券之星 · 10-08
10月8日红日药业涨9.58%,银河康乐股票A基金重仓该股
红日药业:目前公司与您提到的公司暂无合作
证券之星 · 09-12
红日药业:目前公司与您提到的公司暂无合作
红日药业:公司产品血必净注射液被纳入登革热诊疗方案(2024版)推荐用药
证券之星 · 09-10
红日药业:公司产品血必净注射液被纳入登革热诊疗方案(2024版)推荐用药
红日药业新注册《网采对接管理平台V1.0》项目的软件著作权
证券之星 · 09-10
红日药业新注册《网采对接管理平台V1.0》项目的软件著作权
红日药业最新公告:公司及相关人员收到天津证监局出具的警示函
证券之星 · 09-06
红日药业最新公告:公司及相关人员收到天津证监局出具的警示函
红日药业:公司及相关人员收到天津证监局出具的警示函
美港电讯 · 09-06
红日药业:公司及相关人员收到天津证监局出具的警示函
红日药业(300026.SZ)及相关人员收到天津证监局出具警示函
智通财经网 · 09-06
红日药业(300026.SZ)及相关人员收到天津证监局出具警示函
红日药业:9月3日召开业绩说明会,投资者参与
证券之星 · 09-03
红日药业:9月3日召开业绩说明会,投资者参与
红日药业(300026)2024年中报简析:净利润减57.14%
证券之星 · 08-31
红日药业(300026)2024年中报简析:净利润减57.14%
红日药业:公司时刻关注行业动态、市场形势,聚焦主营业务的同时寻求创新发展
证券之星 · 08-29
红日药业:公司时刻关注行业动态、市场形势,聚焦主营业务的同时寻求创新发展
图解红日药业中报:第二季度单季净利润同比减47.12%
证券之星 · 08-29
图解红日药业中报:第二季度单季净利润同比减47.12%
红日药业(300026)6月30日股东户数11.17万户,较上期减少5.88%
证券之星 · 08-29
红日药业(300026)6月30日股东户数11.17万户,较上期减少5.88%
红日药业最新公告:上半年净利润同比下降57.14%
证券之星 · 08-29
红日药业最新公告:上半年净利润同比下降57.14%
红日药业(300026.SZ)发上半年业绩,净利润1.48亿元,同比减少57.14%
智通财经 · 08-29
红日药业(300026.SZ)发上半年业绩,净利润1.48亿元,同比减少57.14%
红日药业:公司目前主要以通用大模型为代表的人工智能技术兴起并应用到产业中,推进通用精细化管理
证券之星 · 08-22
红日药业:公司目前主要以通用大模型为代表的人工智能技术兴起并应用到产业中,推进通用精细化管理
红日药业:公司暂无应对猴痘的检测方法和治疗药剂
证券之星 · 08-19
红日药业:公司暂无应对猴痘的检测方法和治疗药剂
8月15日红日药业现1笔折价10.06%的大宗交易 合计成交117.18万元
证券之星 · 08-15
8月15日红日药业现1笔折价10.06%的大宗交易 合计成交117.18万元
公司概况
公司名称:
天津红日药业股份有限公司
所属行业:
医药制造业
上市日期:
2009-10-30
主营业务:
天津红日药业股份有限公司是一家主要从事药品及医疗器械的生产经营和研究开发,主要产品包括:血必净注射液、盐酸法舒地尔注射液(川威)、低分子量肝素钙注射液(博璞青)、中药配方颗粒、医疗器械、药用辅料等。公司获得国家发改委发布的全国制药行业企业信用评价AAA级,荣获国家知识产权优势企业、全国药品不良反应监测评价工作优秀单位称号,公司“新药转移突击队”获评“全国工人先锋号”,获得中国医药工业百强企业排名第41位,中成药企业百强第15位。
发行价格:
60.00
{"stockData":{"symbol":"300026","market":"SZ","secType":"STK","nameCN":"红日药业","latestPrice":4.13,"timestamp":1732074060000,"preClose":4.07,"halted":0,"volume":35063295,"delay":0,"floatShares":2686000000,"shares":3004000000,"eps":0.0552,"marketStatus":"午间休市","marketStatusCode":3,"change":0.06,"latestTime":"11-20 11:30:00","open":4.05,"high":4.14,"low":4.04,"amount":144000000,"amplitude":0.0246,"askPrice":4.14,"askSize":10713,"bidPrice":4.13,"bidSize":1580,"shortable":0,"etf":0,"ttmEps":0.0552,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732078800000},"adr":0,"adjPreClose":4.07,"symbolType":"stock","openAndCloseTimeList":[[1732066200000,1732073400000],[1732078800000,1732086000000]],"highLimit":4.48,"lowLimit":3.66,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":3004154837,"pbRate":1.39,"roa":"--","roe":"1.92%","epsLYR":0.17,"committee":-0.197175,"marketValue":12407000000,"floatMarketCap":11093000000,"peRate":74.818841,"changeRate":0.0147,"turnoverRate":0.0131,"status":0},"requestUrl":"/m/hq/s/300026/wiki","defaultTab":"wiki","newsList":[{"id":"2478608688","title":"10月25日红日药业现2笔折价20%的大宗交易 合计成交2187.81万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478608688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478608688?lang=zh_cn&edition=full","pubTime":"2024-10-25 16:51","pubTimestamp":1729846265,"startTime":"0","endTime":"0","summary":"证券之星消息,10月25日红日药业发生大宗交易,交易数据如下:近三个月该股共发生7笔大宗交易,合计成交16.07万手,折价成交7笔。该股近期无解禁股上市。截至2024年10月25日收盘,红日药业(300026)报收于4.05元,上涨0.25%,换手率2.78%,成交量74.74万手,成交额3.01亿元。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500027708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300026","BK0239","BK0077","BK0188"],"gpt_icon":0},{"id":"2477768679","title":"红日药业(300026.SZ)发布前三季度业绩,净利润1.68亿元,同比下降66.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477768679","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477768679?lang=zh_cn&edition=full","pubTime":"2024-10-24 19:22","pubTimestamp":1729768921,"startTime":"0","endTime":"0","summary":"智通财经APP讯,红日药业(300026.SZ)发布2024年第三季度报告,公司前三季度营业收入44.41亿元,同比下降9.78%;归属于上市公司股东的净利润1.68亿元,同比下降66.94%;归属于上市公司股东的扣除非经常性损益的净利润1.58亿元,同比下降64.12%;基本每股收益0.06元/股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1199094.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300026"],"gpt_icon":0},{"id":"2477505517","title":"红日药业(300026)9月30日股东户数11.08万户,较上期减少0.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477505517","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477505517?lang=zh_cn&edition=full","pubTime":"2024-10-24 17:05","pubTimestamp":1729760734,"startTime":"0","endTime":"0","summary":"证券之星消息,近日红日药业披露,截至2024年9月30日公司股东户数为11.08万户,较6月30日减少849.0户,减幅为0.76%。在中药行业个股中,红日药业股东户数高于行业平均水平,截至9月30日,中药行业平均股东户数为4.94万户。从股价来看,2024年6月30日至2024年9月30日,红日药业区间涨幅为33.44%,在此期间股东户数减少849.0户,减幅为0.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400028241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0077","300026","BK0239"],"gpt_icon":0},{"id":"2473446124","title":"10月8日红日药业涨9.58%,银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2473446124","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473446124?lang=zh_cn&edition=full","pubTime":"2024-10-08 17:35","pubTimestamp":1728380109,"startTime":"0","endTime":"0","summary":"证券之星消息,10月8日红日药业涨9.58%创60日新高,收盘报4.46元,换手率8.84%,成交量237.35万手,成交额10.68亿元。重仓红日药业的公募基金请见下表:根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为银河康乐股票A。银河康乐股票A的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100800026326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300026","BK0077","BK0188"],"gpt_icon":0},{"id":"2466246482","title":"红日药业:目前公司与您提到的公司暂无合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2466246482","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466246482?lang=zh_cn&edition=full","pubTime":"2024-09-12 18:03","pubTimestamp":1726135435,"startTime":"0","endTime":"0","summary":"证券之星消息,红日药业09月12日在投资者关系平台上答复投资者关心的问题。收到时间均为2024年9月6号。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091200029975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0077","300026"],"gpt_icon":0},{"id":"2466452177","title":"红日药业:公司产品血必净注射液被纳入登革热诊疗方案(2024版)推荐用药","url":"https://stock-news.laohu8.com/highlight/detail?id=2466452177","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466452177?lang=zh_cn&edition=full","pubTime":"2024-09-10 23:00","pubTimestamp":1725980438,"startTime":"0","endTime":"0","summary":"证券之星消息,红日药业09月10日在投资者关系平台上答复投资者关心的问题。公司有没有治疗登革热病毒的药物,请回答红日药业董秘:您好,公司产品血必净注射液被纳入登革热诊疗方案推荐用药,谢谢关注。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091000037999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","300026","BK0239"],"gpt_icon":0},{"id":"2466115651","title":"红日药业新注册《网采对接管理平台V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2466115651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466115651?lang=zh_cn&edition=full","pubTime":"2024-09-10 01:25","pubTimestamp":1725902729,"startTime":"0","endTime":"0","summary":"证券之星消息,近日红日药业(300026)新注册了《网采对接管理平台V1.0》项目的软件著作权。今年以来红日药业新注册软件著作权5个,较去年同期增加了25%。结合公司2024年中报财务数据,今年上半年公司在研发方面投入了9369.01万元,同比减7.41%。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091000001627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300026","BK0239","BK0077","BK0188"],"gpt_icon":0},{"id":"2465656606","title":"红日药业最新公告:公司及相关人员收到天津证监局出具的警示函","url":"https://stock-news.laohu8.com/highlight/detail?id=2465656606","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465656606?lang=zh_cn&edition=full","pubTime":"2024-09-06 17:11","pubTimestamp":1725613887,"startTime":"0","endTime":"0","summary":"红日药业公告称,公司于近日收到天津证监局出具的《警示函》。2023年,红日药业与甘肃佛慈红日药业销售有限公司发生关联交易5591.35万元,但未履行相关审议程序,也未及时披露相关临时公告。天津证监局决定对红日药业及时任董事长姚小青、总经理郑丹、董事会秘书杨伊采取出具警示函的监督管理措施。公司及相关人员已高度重视,并深刻吸取教训,加强证券法规学习,提高信息披露质量。本次监管措施不会影响公司的正常生产经营活动。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090600026947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300026","BK0077","BK0188"],"gpt_icon":0},{"id":"2465166582","title":"红日药业:公司及相关人员收到天津证监局出具的警示函","url":"https://stock-news.laohu8.com/highlight/detail?id=2465166582","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465166582?lang=zh_cn&edition=full","pubTime":"2024-09-06 17:10","pubTimestamp":1725613829,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["161027","300026","BK0239","BK0077","BK0188"],"gpt_icon":0},{"id":"2465663223","title":"红日药业(300026.SZ)及相关人员收到天津证监局出具警示函","url":"https://stock-news.laohu8.com/highlight/detail?id=2465663223","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465663223?lang=zh_cn&edition=full","pubTime":"2024-09-06 17:06","pubTimestamp":1725613584,"startTime":"0","endTime":"0","summary":"红日药业(300026.SZ)公告,公司近日收到中国证券监督管理委员会天津监管局(...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/25.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/25.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1180257.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0188","BK0239","300026","BK0077"],"gpt_icon":0},{"id":"2464285802","title":"红日药业:9月3日召开业绩说明会,投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2464285802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464285802?lang=zh_cn&edition=full","pubTime":"2024-09-03 21:55","pubTimestamp":1725371704,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年9月3日红日药业发布公告称公司于2024年9月3日召开业绩说明会。主要是配方颗粒及饮片收入同比下降导致。截至公司 2024 年半年度报告批准日,公司于 2024 年 8 月23日已全额提前偿还 6亿元公司债券,偿还资金主要来源于公司日常经营所产生的利润和现金流,偿还公司债券后公司整体运营资金充足,公司经营支付业务正常,财务风险可控。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090300037804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","300026","BK0239","BK0077"],"gpt_icon":0},{"id":"2463715790","title":"红日药业(300026)2024年中报简析:净利润减57.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463715790","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463715790?lang=zh_cn&edition=full","pubTime":"2024-08-31 06:28","pubTimestamp":1725056881,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期红日药业发布2024年中报。根据财报显示,红日药业净利润减57.14%。截至本报告期末,公司营业总收入29.96亿元,同比下降12.48%,归母净利润1.48亿元,同比下降57.14%。其中,毛利率52.95%,同比减7.33%,净利率5.09%,同比减50.14%,销售费用、管理费用、财务费用总计12.68亿元,三费占营收比42.33%,同比增0.41%,每股净资产2.92元,同比增2.53%,每股经营性现金流0.12元,同比减24.24%,每股收益0.05元,同比减58.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083100009040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300026"],"gpt_icon":0},{"id":"2463872902","title":"红日药业:公司时刻关注行业动态、市场形势,聚焦主营业务的同时寻求创新发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2463872902","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463872902?lang=zh_cn&edition=full","pubTime":"2024-08-29 18:05","pubTimestamp":1724925931,"startTime":"0","endTime":"0","summary":"证券之星消息,红日药业(300026)08月29日在投资者关系平台上答复投资者关心的问题。投资者:董秘你好,公司业绩下降、股价一跌再跌,请问新任吴董事长就任后,应对这不利的局面做出了哪些经营调整、行业布局呢?对公司创新药研制做出长远规划来保证公司未来十年、二十年的业绩能正常正常呢?红日药业董秘:您好,公司时刻关注行业动态、市场形势,聚焦主营业务的同时寻求创新发展。感谢关注!以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900034729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300026","BK0077","BK0188","BK0239"],"gpt_icon":0},{"id":"2463928437","title":"图解红日药业中报:第二季度单季净利润同比减47.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463928437","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463928437?lang=zh_cn&edition=full","pubTime":"2024-08-29 17:37","pubTimestamp":1724924235,"startTime":"0","endTime":"0","summary":"证券之星消息,红日药业2024年中报显示,公司主营收入29.96亿元,同比下降12.48%;归母净利润1.48亿元,同比下降57.14%;扣非净利润1.37亿元,同比下降57.19%;其中2024年第二季度,公司单季度主营收入15.33亿元,同比下降13.12%;单季度归母净利润9011.14万元,同比下降47.12%;单季度扣非净利润8289.6万元,同比下降49.25%;负债率25.73%,投资收益-123.38万元,财务费用1950.2万元,毛利率52.95%。财报数据概要请见下图: 以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900033749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300026"],"gpt_icon":0},{"id":"2463286087","title":"红日药业(300026)6月30日股东户数11.17万户,较上期减少5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463286087","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463286087?lang=zh_cn&edition=full","pubTime":"2024-08-29 17:13","pubTimestamp":1724922835,"startTime":"0","endTime":"0","summary":"证券之星消息,近日红日药业披露,截至2024年6月30日公司股东户数为11.17万户,较3月31日减少6980.0户,减幅为5.88%。在中药行业个股中,红日药业股东户数高于行业平均水平,截至6月30日,中药行业平均股东户数为4.98万户。从股价来看,2024年3月31日至2024年6月30日,红日药业区间跌幅为21.36%,在此期间股东户数减少6980.0户,减幅为5.88%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900031726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300026","BK0188","BK0239","BK0077"],"gpt_icon":0},{"id":"2463283741","title":"红日药业最新公告:上半年净利润同比下降57.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463283741","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463283741?lang=zh_cn&edition=full","pubTime":"2024-08-29 16:50","pubTimestamp":1724921449,"startTime":"0","endTime":"0","summary":"红日药业2024年半年度报告摘要显示,公司上半年实现营业收入29.96亿元,同比下降12.48%;归属于上市公司股东的净利润1.48亿元,同比下降57.14%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900029441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300026"],"gpt_icon":0},{"id":"2463928868","title":"红日药业(300026.SZ)发上半年业绩,净利润1.48亿元,同比减少57.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463928868","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463928868?lang=zh_cn&edition=full","pubTime":"2024-08-29 16:29","pubTimestamp":1724920174,"startTime":"0","endTime":"0","summary":"智通财经APP讯,红日药业(300026.SZ)发布2024年半年度报告,报告期内公司实现营业收入29.96亿元,同比减少12.48%;归属于上市公司股东的净利润1.48亿元,同比减少57.14%;归属于上市公司股东扣除非经常性损益净利润1.37亿元,同比减少57.19%;基本每股收益0.05元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1174644.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300026"],"gpt_icon":0},{"id":"2461733399","title":"红日药业:公司目前主要以通用大模型为代表的人工智能技术兴起并应用到产业中,推进通用精细化管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2461733399","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461733399?lang=zh_cn&edition=full","pubTime":"2024-08-22 18:04","pubTimestamp":1724321055,"startTime":"0","endTime":"0","summary":"红日药业董秘:您好,血必净注射液的适应症是用于温热类疾病,症见发热、喘促、心悸、烦燥等瘀毒互结证;适用于因感染诱发的全身炎症反应综合征;也可配合治疗多器官功能失常综合征的脏器功能受损期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082200033209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","161631","300026","BK0239","BK0188"],"gpt_icon":0},{"id":"2460208690","title":"红日药业:公司暂无应对猴痘的检测方法和治疗药剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2460208690","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460208690?lang=zh_cn&edition=full","pubTime":"2024-08-19 18:04","pubTimestamp":1724061857,"startTime":"0","endTime":"0","summary":"证券之星消息,红日药业(300026)08月19日在投资者关系平台上答复投资者关心的问题。投资者:请问贵公司有没有应对猴痘的检测方法,或治疗药剂。红日药业董秘:您好,公司暂无应对猴痘的检测方法和治疗药剂。感谢您的关注!投资者:近期是否有大股东减持?为何出现频繁折价大宗交易的情况?红日药业董秘:您好,大宗交易属于二级市场上正常的市场交易行为。感谢关注!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081900024749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0077","300026"],"gpt_icon":0},{"id":"2459417382","title":"8月15日红日药业现1笔折价10.06%的大宗交易 合计成交117.18万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459417382","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459417382?lang=zh_cn&edition=full","pubTime":"2024-08-15 16:40","pubTimestamp":1723711234,"startTime":"0","endTime":"0","summary":"证券之星消息,8月15日红日药业发生大宗交易,交易数据如下:大宗交易成交价格3.13元,相对当日收盘价折价10.06%,成交37.44万股,成交金额117.18万元,买方营业部为山西证券股份有限公司太原平阳路证券营业部,卖方营业部为华龙证券股份有限公司北京安外大街证券营业部。近三个月该股共发生5笔大宗交易,合计成交9.32万手,折价成交5笔。截至2024年8月15日收盘,红日药业报收于3.48元,上涨0.29%,换手率2.05%,成交量56.45万手,成交额1.99亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081500032436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300026","BK0239","BK0188","BK0077"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2009-10-30","address":"天津市武清区新技术产业园区武清开发区泉发路西","stockEarnings":[{"period":"1week","weight":-0.0874},{"period":"1month","weight":0.0383},{"period":"3month","weight":0.2562},{"period":"6month","weight":0.1212},{"period":"1year","weight":-0.11},{"period":"ytd","weight":-0.0323}],"companyName":"天津红日药业股份有限公司","boardCode":"AI0027","perCapita":"24235股","boardName":"医药制造业","registeredCapital":"300415万元","compareEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":0.0259},{"period":"3month","weight":0.1713},{"period":"6month","weight":0.0737},{"period":"1year","weight":0.0905},{"period":"ytd","weight":0.1247}],"survey":" 天津红日药业股份有限公司是一家主要从事药品及医疗器械的生产经营和研究开发,主要产品包括:血必净注射液、盐酸法舒地尔注射液(川威)、低分子量肝素钙注射液(博璞青)、中药配方颗粒、医疗器械、药用辅料等。公司获得国家发改委发布的全国制药行业企业信用评价AAA级,荣获国家知识产权优势企业、全国药品不良反应监测评价工作优秀单位称号,公司“新药转移突击队”获评“全国工人先锋号”,获得中国医药工业百强企业排名第41位,中成药企业百强第15位。","serverTime":1732074094539,"listedPrice":60,"stockholders":"110822人(较上一季度减少0.76%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"红日药业(300026)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供红日药业(300026)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"红日药业,300026,红日药业股票,红日药业股票老虎,红日药业股票老虎国际,红日药业行情,红日药业股票行情,红日药业股价,红日药业股市,红日药业股票价格,红日药业股票交易,红日药业股票购买,红日药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"红日药业(300026)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供红日药业(300026)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}